Yiping Zou

7PUBLICATIONS
24CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 03, 2023
Survival outcomes of neoadjuvant therapy followed by radical resection versus upfront surgery for stage I-III pancreatic ductal adenocarcinoma: a retrospective cohort study.

Yiping Zou, Song Gao, Xin Yu

|Sep 12, 2022
Nomogram Based on Inflammatory Biomarkers to Predict the Recurrence of Hepatocellular Carcinoma-A Multicentre Experience.

Zehao Zheng, Renguo Guan, Yiping Zou

|Aug 27, 2021
A Novel Prognostic Nomogram for Gallbladder Cancer after Surgical Resection: A Single-Center Experience.

Zuyi Ma, Fengying Dong, Zhenchong Li

|Aug 16, 2021
SLC39A10 Upregulation Predicts Poor Prognosis, Promotes Proliferation and Migration, and Correlates with Immune Infiltration in Hepatocellular Carcinoma.

Zuyi Ma, Zhenchong Li, Shujie Wang

|Jul 05, 2021
Development and Validation of a Nomogram Based on Noninvasive Liver Reserve and Fibrosis (PALBI and FIB-4) Model to Predict Posthepatectomy Liver Failure Grade B-C in Patients with Hepatocellular Carcinoma.

Wenhui Zhong, Feng Zhang, Kaijun Huang

|Mar 22, 2021
Identification of Prognostic and Therapeutic Biomarkers among FAM83 Family Members for Pancreatic Ductal Adenocarcinoma.

Zuyi Ma, Zixuan Zhou, Hongkai Zhuang

Pageof 2

Frequent Collaborators

3 joint publications

Zuyi Ma

3 joint publications

Baohua Hou

3 joint publications

Chuanzhao Zhang

2 joint publications

Hongkai Zhuang